Trial Profile
A retrospective study of gemcitabine in patients with locally advanced non resectable or metastatic pancreatic cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Oct 2015
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 06 Oct 2015 New trial record